FR941221-1-00041 FR941221-1-00012 8. Section 173.134 would be revised to read as follows: §173.134 Class 6, Division 6.2_Definitions, exceptions and packing group assignments. (a) Definitions. For the purposes of this subchapter, the categories of materials that comprise Division 6.2 are defined as follows: (1) An infectious substance means a viable microorganism, or its toxin, which causes or may cause disease in humans or animals, and includes those agents listed in 42 CFR 72.3 of the regulations of the Department of Health and Human Services and any other agent that causes or may cause severe, disabling or fatal disease. The terms infectious substance and etiologic agent are synonymous. (2) A diagnostic specimen means any human or animal material being shipped for purposes of diagnosis which contains an infectious substance including, but not limited to, excreta, secreta, blood, blood components, tissue, and tissue fluids. (3) A biological product means a material which contains an infectious substance and is prepared and manufactured in accordance with the provisions of 9 CFR part 102 (Licenses for biological products), 9 CFR part 103 (Experimental products, distribution, and evaluation of biological products prior to licensing), 9 CFR part 104 (Permits for biological products), 21 CFR part 312 (Investigational new drug application), or 21 CFR parts 600 to 680 (Biologics). (4) A regulated medical waste means a waste or reusable material, other than a Class 7 (radioactive) material or a culture or stock of an infectious substance, which contains an infectious substance and is generated in_ (i) The diagnosis, treatment or immunization of human beings or animals; (ii) Research pertaining to the diagnosis, treatment or immunization of human beings or animals; or (iii) The production or testing of biological products. (b) Exceptions. (1) The following are not subject to any requirements of this subchapter if the items as packaged do not contain any material otherwise subject to the requirements of this subchapter: (i) Biological products; (ii) Diagnostic specimens; (iii) Laundry or medical equipment which conforms to 29 CFR 1910.1030 of the regulations of the Occupational Safety and Health Administration of the Department of Labor; (iv) A material, including waste, which previously contained an infectious substance, that has been treated by steam sterilization, chemical disinfection, or other appropriate methods, so that it no longer poses the hazard of an infectious substance; (v) Household waste, i.e., any waste material, including garbage, trash and sanitary waste in septic tanks, derived from households, including single and multiple residences, hotels and motels; (vi) Corpses, remains and anatomical parts that are intended for ceremonial interment or cremation; and (vii) Animal waste generated in animal husbandry or food production. (2) A hazardous waste is not subject to regulation as a regulated medical waste. (3) A regulated medical waste that is transported by a private or contract carrier is excepted from_ (i) The requirement for an ``INFECTIOUS SUBSTANCE'' label if the outer packaging is marked with a ``BIOHAZARD'' marking in accordance with 29 CFR 1910.1030; and (ii) The specific packaging requirements of §173.197, if packaged in a rigid non-bulk packaging conforming to_ (A) The general packaging requirements of §§173.24 and 173.24a; and (B) Packaging requirements specified in 29 CFR 1910.1030. (c) Assignment of packing groups/applicable packaging sections. (1) Division 6.2 materials, other than regulated medical waste, are not assigned a packing group. Packaging requirements for these materials are prescribed in §173.196. (2) Except as otherwise provided, regulated medical waste is assigned to Packing Group II and must be packaged as specified in §173.197. Appendix G [Removed] 9. Appendix G to part 173 would be removed. PART 178_SPECIFICATIONS FOR PACKAGINGS 10. The authority citation for part 178 would continue to read as follows: Authority: 49 U.S.C. 5101&hyph;5127; 49 CFR 1.53. 11. In §178.609, paragraph (i) would be added to read as follows: §178.609 Test requirements for packagings for infectious substances (etiologic agents). * * * * * (i) Packagings subject to this section are not subject to §178.503 or any other requirements of this subpart, except §178.608. Issued in Washington, DC on December 14, 1994, under authority delegated in 49 CFR part 106, appendix A. Alan I. Roberts, Associate Administrator for Hazardous Materials Safety. [FR Doc. 94&hyph;31174 Filed 12&hyph;20&hyph;94; 8:45 am] BILLING CODE 4910&hyph;60&hyph;P
